Related Experiment Video
Updated: Aug 18, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Coinfection with HIV and HCV--epidemiologic, diagnostic, clinical and therapeutic implications]
1Katedra i Klinika Chorób Zakaźnych i Hepatologii, Uniwersytet Medyczny w Lodzi.
Insights
Coinfection with HIV and HCV is common due to shared transmission. HIV may accelerate HCV liver disease, making treatment complex for co-infected patients.
Area of Science:
- Hepatology and Virology
- Infectious Diseases
- Immunology
Context:
- Coinfection with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) is prevalent due to shared transmission routes.
- HIV may act as a cofactor, increasing heterosexual and perinatal HCV transmission.
- Increased survival in patients on Highly Active Antiretroviral Therapy (HAART) highlights the critical need to manage liver disease in co-infected individuals, as it is a leading cause of mortality.
Purpose:
- To review the clinical implications of HIV-HCV coinfection.
- To discuss the impact of HIV on HCV progression and vice versa.
- To outline the challenges and considerations in managing coinfected patients.
Summary:
- HIV-HCV coinfection is common, with HIV potentially accelerating HCV-related liver disease progression.
- The effect of HCV on HIV disease progression remains debated.
- Treatment for coinfected patients is challenging, requiring careful consideration of patient immunity, liver disease severity, potential hepatotoxicity, and drug interactions.
Impact:
- Highlights the critical importance of managing liver disease in HIV-HCV coinfected patients.
- Emphasizes the complexity of treatment decisions for coinfected individuals.
- Underscores the need for further research into the interactions between HIV and HCV.
Abstract:
Because of shared transmission pathways, coinfection with HIV and HCV is common. Besides evidence is accumulating that HIV infection may be a cofactor for heterosexual and perinatal transmission of HCV infection. The increasing survival of patients on HAART has emphasized the importance of treating liver disease because co-infected patients are now often dying of their liver disease. There is a common opinion that HIV infection causes rapid and more severe course of HCV-related liver disease. The impact of HCV infection on HIV disease progression is controversial. The treatment of patients co-infected with HIV and HCV is difficult. Therapeutic options depend on immunological status of patients and severity of liver disease. In addition hepatotoxicity and drug interactions should be considered.
Related Concept Videos
Hepatitis
Retrovirus Life Cycles
Sexually Transmitted Infections
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Infectious Diseases and Their Occurrence